AGI Fabricators, a provider of metal structural fabrication solutions, today emphasizes the breadth of its fabrication and ...

Rob Abbott, CEO, ISPOR, highlights how uniting regulators, payers, and academic leaders worldwide can accelerate access to innovative treatments and strengthen evidence-based healthcare.

On May 12, Trump signed an executive order stating that U.S. consumers are being overcharged for prescription drugs and that “Americans must therefore have access to the most-favored-nation price.” ...

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.

A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the Indian pharmaceutical industry. Manufacturers are now forced ...

In the third part of his Pharma Commerce video interview, Dave Malenfant, a healthcare supply chain expert, discusses how predictive analytics, AI, and automation are streamlining US pharmaceutical ...

Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives ...

Natco Pharma launches Bosentan tablets, generic version of Tracleer, with 180-day exclusivity in the U.S. for PAH treatment.

The CDMO will be cutting 350 jobs at its Baltimore gene therapy site after a major client’s demand shift, less than a year after Novo Holdings’ $16.5 billion acquisition.

Nearly two-thirds of US drug production facilities are located in areas that have had a major disaster like a fire or ...

In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

The American Academy of Pediatrics’ new vaccine schedule differs from government recommendations. Mr. Funk was the managing ...